InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Grossman Adam S, Chief Executive Officer. Insider active across 1 companies, notably Adma Biologics, INC.. Aggregated, 7 reports have been logged. Total volume traded: €172k. The latest transaction was filed on 11 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€95,22670,004 shares@ €1.36030.0050% mcap28.5% of flow
Common Stock
SEC:0001140361-22-019215:0·
€66,89850,539 shares@ €1.32370.0035% mcap20.0% of flow
Common Stock
SEC:0001140361-22-011249:0·
0300,000 shares0
Common Stock
SEC:0001140361-22-008671:0·
€86,120100,000 shares@ €0.86120.0045% mcap100.0% of flow
Common Stock
SEC:0001140361-21-035379·
Ideal exit: 22 Jul 2022 (T+270)
€86,120100,000 shares@ €0.86120.0045% mcap25.8% of flow
Common Stock
SEC:0001140361-21-035379:0·
Ideal exit: 22 Jul 2022 (T+270)
0907,500 shares0
Common Stock
SEC:0001140361-21-033354·
0907,500 shares0
Common Stock
SEC:0001140361-21-033354:0·
7 of 7 declarations
About Grossman Adam S
Adam S. Grossman is the President and CEO of ADMA BIOLOGICS, INC. He leads the company and is responsible for implementing the overall strategy. Adam plays a key role in directing operations and developing new biological products.
